Company Filing History:
Years Active: 1990
Title: Ellyn Fischberg-Bender: A Pioneer in Antibody Innovation
Introduction: Ellyn Fischberg-Bender is a notable inventor based in Ossining, NY, recognized for her contributions to the field of biotechnology. With one patent to her name, her work focuses on groundbreaking advancements in the understanding of the ras protein, which is integral to cancer research and treatment.
Latest Patents: Ellyn Fischberg-Bender's patent, titled "Antibodies for transforming ras protein," outlines the preparation of novel polypeptide sequences that span amino acid position 61 of the ras protein. These innovative sequences are characterized by the presence of leucine at this position, replacing the usual glutamine found in normal ras protein. The patent discusses the utilization of these polypeptides to prepare immunogen compositions and antibodies, specifically targeting the P21Tleu61 transforming protein. This work is crucial for developing immunoassays and immunochemical methods to detect the presence of this protein, enhancing research in cancer diagnostics.
Career Highlights: Fischberg-Bender works at Hoffmann-La Roche Inc., a leading company in pharmaceutical and biotech research. Her career at this esteemed organization allows her to collaborate with other talented minds in the industry and make significant strides in her field. Her focus on transforming proteins and antibody production represents a vital area of research with potential implications for therapeutic interventions.
Collaborations: Throughout her career, Ellyn has worked alongside esteemed colleagues, including Diane Bizub and Anna Marie Skalka. These collaborations are pivotal in fostering a productive work environment and driving innovative projects forward, enhancing the overall research output at Hoffmann-La Roche Inc.
Conclusion: Ellyn Fischberg-Bender's commitment to innovation and her work on antibodies for the ras protein exemplifies the transformative nature of modern biotechnological research. Her contributions not only contribute to scientific knowledge but also pave the way for future advancements in cancer therapies. As a leading inventor in her field, Fischberg-Bender continues to inspire and influence the scientific community through her groundbreaking work.